Biosig technologies chief executive officer mr. anthony amato issues the following letter to shareholders

Westport, ct, may 21, 2024 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or “company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, has today issued the following letter to shareholders:
BSGM Ratings Summary
BSGM Quant Ranking